ArticleRheumatology international2023

Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease.

Alexandros Panagiotopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.